Samsung Biologics reported consolidated revenue of 4.5569 trillion won and operating profit of 2.0692 trillion won last year, marking all-time highs.23
The union demands a 14% wage increase, 30 million won incentive per employee, performance bonus of 20% of operating profit, and company shares allocation.123
Management offered a 6.2% wage increase; negotiations broke down after 13 rounds.13
Union voted overwhelmingly for strike (95.52% approval) and plans first-ever action from May 1-5, with full strike possibly on May 21.123
Rally held on April 22 with ~2,000 participants protesting 'insincere bargaining' after HR data leak.2
Strike risks disrupting CDMO operations and 15 trillion won investment strategy in competitive global market.3
Sources:
1. https://www.mk.co.kr/en/business/12024307
2. https://biz.chosun.com/en/en-science/2026/04/22/TD43BH4SBJFUTKRTDAAPZ4PYTE/
3. https://en.sedaily.com/markets/2026/03/29/samsung-biologics-faces-first-strike-in-15-year-history